
Behavioral and Cognitive Effects of MethylxanthinesA Meta-analysis of Theophylline and Caffeine
Mark A. Stein, PhD;
Matthew Krasowski;
Bennett L. Leventhal, MD;
Warren Phillips;
Bruce G. Bender, PhD
Arch Pediatr Adolesc Med. 1996;150(3):284-288.
Abstract
Background Theophylline has been extensively studied as a treatment of asthma. However, some studies have suggested that theophylline may precipitate adverse behavioral and cognitive effects on children. Other reports have evaluated the effects of caffeine, another commonly used methylxanthine, as a treatment of attentiondeficit hyperactivity disorder.
Objective To present a meta-analysis of research on the behavioral and cognitive effects of methylxanthines in children.
Methods The meta-analyses were conducted on 12 studies of theophylline and nine studies of caffeine that met inclusion criteria.
Results In contrast to popular beliefs and earlier scientific reports, meta-analyses of controlled studies did not indicate that either theophylline or caffeine resulted in significant deleterious effects on cognition or behavior. In fact, there was a small, positive effect on parental report of externalizing behavior for both methylxanthines.
Conclusions There is little evidence to suggest that methylxanthines have adverse cognitive or behavioral effects on children. Questions remain with regard to the identification and determinants of either responsive or sensitive subgroups, dose-response relationships, and the effects of parent-teacher expectancies on behavioral ratings.
(Arch Pediatr Adolesc Med. 1996;150:284-288)
Author Affiliations
From the Section of Child and Adolescent Psychiatry, Departments of Psychiatry and Pediatrics, The University of Chicago (Ill) (Drs Stein and Leventhal and Messrs Krasowski and Phillips), and the National Jewish Center for Immunology and Respiratory Medicine and Department of Psychiatry, University of Colorado, Boulder (Dr Bender).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
Winckworth and Powell
Arch. Dis. Child. 2010;95:757-759.
FULL TEXT
How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis
Schachter et al.
CMAJ 2001;165:1475-1488.
ABSTRACT
| FULL TEXT
Guides for Reading and Interpreting Systematic Reviews: I. Getting Started
Klassen et al.
Arch Pediatr Adolesc Med 1998;152:700-704.
FULL TEXT
Neuropsychological and Behavioral Changes in Asthmatic Children Treated With Beclomethasone Dipropionate Versus Theophylline
Bender et al.
Pediatrics 1998;101:355-360.
ABSTRACT
| FULL TEXT
Caffeine as a Stimulant Against Suicide
Szekely
Arch Intern Med 1997;157:243-244.
ABSTRACT
|